Accuray Incorporated
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Accuray Incorporated's yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, is 9.0 times its market value (net debt). Lower than almost all Healthcare companies in United States.
- Cash Locked Ratio: For every $100 of sales, $45 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $41 tied up three years earlier. More money tied up than 89% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Jun 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-0.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Higher than 62% of Healthcare companies in United States.
Cash Locked Ratio
$45For every $100 of sales, $45 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $41 tied up three years earlier.
More money tied up than 89% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 10%
Sales fell 10% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-10% / -7%In 3 years sales changed by -10% while total assets changed by -7%. Both moved at about the same pace.
Balance-sheet strength
Debt Due Cover Ratio
-4.7×Operating cash was negative last year, while some debt falls due within a year.
Higher than 60% of Healthcare companies in United States.
Cash Cushion Ratio
9.0× debtDebt, after subtracting cash, is 9.0 times its market value (net debt).
Lower than almost all Healthcare companies in United States.
Tangible Assets Ratio
87%Of every $100 the company owns, $87 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 58% of Healthcare companies in United States.
Tangible Net Worth Ratio
NegativeGoodwill and other intangibles are larger than its whole net worth, so its tangible net worth is negative.
Less tangible than 84% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
Accuray Incorporated made a loss over the last year. Accuray Incorporated owes $0.91 for every $1 it owns. Accuray Incorporated made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Jun 2026.
P/E ratio
LossAccuray Incorporated made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.38The share price is 0.38 times Accuray Incorporated's book value per share, lower than 94% of Healthcare companies in United States.
Market cap
$16 MThe total market value of all of Accuray Incorporated's shares at today's price (share price × number of shares), smaller than 84% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$42 MWhat Accuray Incorporated would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.35Net worth divided by the number of shares. The share price of $0.13 is 0.4 times this, which is the P/B above.
Return on equity (ROE)
-80.1%Accuray Incorporated lost 80.1% of its shareholders' money over the last year, lower than 65% of Healthcare companies in United States.
Owes vs Owns
0.91×Accuray Incorporated owes $0.91 for every $1 it owns (high), higher than 83% of Healthcare companies in United States.
Dividend yield
NoneAccuray Incorporated does not currently pay a dividend.
Revenue growth
-12%Revenue fell 12% in the year to Jun 2026, and shrank 4% a year on average over 3 years.
Profit growth
LossAccuray Incorporated made a loss in each of the last two years.
Profit margin
-12.2%Accuray Incorporated lost $12 for every $100 of revenue.
Interest cover
Not coveredAccuray Incorporated's operating profit did not cover its interest costs in the year to Jun 2026.
Cash vs debt
Net debtAccuray Incorporated had $143 M more debt than cash (net debt) at Jun 2026.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Accuray Incorporated: $16 M ÷ $42 M (30 Jun 2026) = 0.4.
What is Accuray Incorporated's return on equity?
Accuray Incorporated lost 80.1% of its shareholders' money over the last year, lower than 65% of Healthcare companies in United States.
How much does Accuray Incorporated owe compared with what it owns?
Accuray Incorporated owes $0.91 for every $1 it owns (high), higher than 83% of Healthcare companies in United States.
Does Accuray Incorporated pay a dividend?
No. Accuray Incorporated does not currently pay a dividend.
Is Accuray Incorporated's revenue growing?
Revenue fell 12% in the year to Jun 2026, and shrank 4% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.